Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

May 9, 2016

Primary Completion Date

July 7, 2017

Study Completion Date

July 7, 2017

Conditions
Pain
Interventions
DRUG

bupivacaine liposome injectable suspension

10 mL EXPAREL (bupivacaine liposome injectable suspension) expanded with 10 mL normal saline

DRUG

bupivacaine liposome injectable suspension

20 mL EXPAREL (bupivacaine liposome injectable suspension)

DRUG

Placebo

20 mL normal saline as single-injection

Trial Locations (20)

3600

Ziekenhuis Oost-Limburg, Genk

8000

Aarhus University Hospital, Aarhus

8600

Regionshospital Silkeborg, Silkeborg

10467

Montefiore Medical Center, The Bronx

15701

Indiana Regional Medical Center, Indiana

15963

Chan Soon-Shiong Medical Center, Windber

19107

Thomas Jefferson University Hospital, Philadelphia

23851

Southampton Orthopedics Sports Medicine, Franklin

27710

Duke University Medical Center, Durham

32504

Pensacola Research Associates, Pensacola

33136

Jackson Memorial Hospital/University of Miami, Miami

36608

Horizon Research Group, Inc, Mobile

44111

Fairview Hospital, Cleveland

75093

Plano Surgical Hospital, Plano

77004

Hermann Drive Surgical Hospital, Houston

77027

Westside Surgical Hospital, Houston

77598

Houston Physician's Hospital, Webster

80113

Denver Metro Orthopedics, Englewood

02115

Brigham and Women's Hospital, Boston

02215

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY